Home
Resources
Publications
Clinical Evaluation of Hydrocortisone Valerate 0.2% Ointment

Clinical Evaluation of Hydrocortisone Valerate 0.2% Ointment

J Sefton, J S Loder, A A Kyriakopoulos

Clin Ther. 1984;6(3):282-93.

PMID: 6373007

Abstract:

Evaluations of the comparative efficacy and safety of hydrocortisone valerate 0.2% ointment were made in six double-blind, multicenter trials involving a total of 485 patients, 209 with atopic dermatitis and 276 with plaque psoriasis. The vasoconstrictor activity of hydrocortisone valerate 0.2% ointment was also assessed in normal subjects. Hydrocortisone valerate 0.2% ointment displayed therapeutic effects within three days. In terms of global evaluations of efficacy, hydrocortisone valerate was more effective than vehicle and was comparable to other intermediate or moderate potency corticosteroid ointments. The vasoconstrictor activity of hydrocortisone valerate 0.2% ointment was greater than that of other moderate potency ointments.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP57524897	Hydrocortisone valerate		57524-89-7	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: